Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open-Label, Randomized, and Multicenter Phase III Clinical Trial Comparing Immunogenicity of [Hepatitis B vaccine recombinant] Double-Dose (40 microg at S0, S4 and S24), Versus Standard Dose Vaccination (20 microg at S0, S4 and S24), Against Hepatitis B Virus in HIV-1-Infected Patients Without Any Previous Immune Response After Primary Immunization Plus One Single Boost

Next Previous
Search
Trial Profile

Open-Label, Randomized, and Multicenter Phase III Clinical Trial Comparing Immunogenicity of [Hepatitis B vaccine recombinant] Double-Dose (40 microg at S0, S4 and S24), Versus Standard Dose Vaccination (20 microg at S0, S4 and S24), Against Hepatitis B Virus in HIV-1-Infected Patients Without Any Previous Immune Response After Primary Immunization Plus One Single Boost

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 09 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hepatitis B vaccine recombinant (HBvaxPro) (Primary)
  • Indications Hepatitis B
  • Focus Pharmacodynamics
  • Acronyms B-BOOST

    • Most Recent Events

    • 06 Jul 2012 Additional lead trial centre (French National Institute for Health and Medical Research) identified as reported by ClinicalTrials.gov.
    • 18 Jan 2012 Planned end date changed from 1 Nov 2010 to 1 Feb 2013 as reported by ClinicalTrials.gov.
    • 18 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top